US89377M1099 - Common Stock
TRANSMEDICS GROUP INC
NASDAQ:TMDX (11/22/2024, 4:07:38 PM)
After market: 76.0324 -0.01 (-0.01%)76.04
-3.3 (-4.16%)
TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 584 full-time employees. The company went IPO on 2019-05-02. The firm specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. The company also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
TRANSMEDICS GROUP INC
200 Minuteman Road
Andover MASSACHUSETTS 01810
P: 19785520900
CEO: Waleed H. Hassanein
Employees: 584
Website: https://www.transmedics.com/
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
This organ transplant specialist is down, but still has plenty of signs of life.
Sales growth is tapering off for this provider of delivery services for transplant organs.
The organ transplant specialist posted disappointing results in its third-quarter report.
TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity.
Here you can normally see the latest stock twits on TMDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: